Petrovax Pharm's pharmaceutical production and warehousing complex (Podolsk District, Moscow Region) was opened in 2008 and is now one of the most advanced high-tech biopharmaceutical facilities in Russia.
It manufactures substances and liquid, semi-solid and solid dosage forms in disposable syringes, ampoules, vials and plastic containers. The production capacity is over 160 m doses of immunobiological medicines per year.
The facility includes a production and warehousing block, laboratories, a power block, a water treatment block, and an office and amenities building.
The complex currently comprises two production lines manufacturing Grippol® Plus and Prevenar® 13 vaccines in pre-filled syringes, along with Polyoxidonium® and Longidaze® in ampoules and vials. Construction of the third production line for substances, solid and semi-solid formulations is now in progress and is due to come on-stream in 2017. As the next step, the company plans to ramp up its production capacity to a total of four lines, expand its warehouse space, and add another office building.
Our Product Quality team currently has more than 80 professionals working to ensure impeccable quality for NPO Petrovax Pharm medicines across all production stages – from taking samples of starting materials to end product quality check.
The production is fully compliant with the Russian and international GMP and ISO:9001 standards. The company is the only producer of immunobiological medicines in Russia holding GMP certificates issued by government regulators from the EU (Slovakia), Ukraine and Iran.